Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Do gwas-identified risk variants for chronic lymphocytic leukemia influence overall patient survival and disease progression?

  • Cabrera-Serrano, Antonio José
  • Espinet Solà, Blanca
  • Blanco Ares, Gonzalo, 1989-
  • Puiggros Metje, Anna Maria
  • Sainz, Juan
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845) and from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades y FEDER (PY20/01282). “The Mayo studies in InterLymph were supported in part by the US National Cancer Institute grants P50 CA97274 and R01 CA92153.”
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

  • García-Martín, Paloma
  • Espinet Solà, Blanca
  • Rodríguez-Sevilla, Juan José
  • Blanco Ares, Gonzalo, 1989-
  • Puiggros Metje, Anna Maria
  • Sainz, Juan
This work was partially supported by the European Union’s Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejería de Economía, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-UGR18); Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Sevilla, Spain; PY20/01282); Generalitat de Catalunya (17SGR437); Gilead Sciences Fellowship (GLD17/00282); the “Xarxa de Bancs de tumors“ sponsored by Pla Director d’Oncologia de Catalunya (XBTC); the Associazione Italiana per la Ricerca sul Cancro and Fondazione Cariplo (TRIDEO 16923 and AIRC IG21436); the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; and the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Polymorphisms within autophagy-related genes as susceptibility biomarkers for multiple myeloma: a meta-analysis of three large cohorts and functional characterization

  • Clavero, Esther
  • Rodríguez-Sevilla, Juan José
  • Sainz, Juan
Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10-9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10-4-5.79 × 10-14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10-4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10-4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10-4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3- B cells, CD5+IgD- cells, IgM- cells, IgD-IgM- cells, and CD4-CD8- PBMCs (p = 4.9 × 10-4-8.6 × 10-4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27- cells (p = 9.3 × 10-4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3-, MCP-2-, and IL20-dependent pathways., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB). This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

  • García Martín, Paloma
  • Moñiz Díez, Ana
  • Sánchez Maldonado, José Manuel
  • Cabrera Serrano, Antonio José
  • Hernández Mohedo, Francisca
  • González Sierra, Pedro Antonio
  • Cañadas Garre, Marisa
  • López Nevot, Miguel Ángel
  • Jurado Chacón, Manuel
  • Sáinz Pérez, Juan|||0000-0002-9355-2423
This work was partially supported by the European Union's Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejeria de Economia, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-UGR18); Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades (Sevilla, Spain; PY20/01282); Generalitat de Catalunya (17SGR437); Gilead Sciences Fellowship (GLD17/00282); the "Xarxa de Bancs de tumors" sponsored by Pla Director d'Oncologia de Catalunya (XBTC); the Associazione Italiana per la Ricerca sul Cancro and Fondazione Cariplo (TRIDEO 16923 and AIRC IG21436); the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; and the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., In conclusion, this study confirmed the association of 31 GWASidentified SNPs with CLL risk and shed some light on the function of some of these biomarkers in the modulation of TReg, B, and T cell differentiation and proliferation, blood concentrations of B cell-related proteins, cell survival, and the expression of immuneand non-immune-related loci. Though outside the scope of the current study, it is important to mention that additional functional studies using blood samples from CLL patients are still required to validate our findings and to decipher the exact biological mechanisms behind the observed associations. A potential limitation of this work was the relatively small population size of the CRuCIAL cohort that hampered the validation of the SNPs showing modest associations., European Union's Horizon 2020 research and innovation program 856620, Instituto de Salud Carlos III PI17/02256 PI20/01845, Consejeria de Economia, Conocimiento, Empresas y Universidad (Granada, Spain) A-CTS-448-UGR18 Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades (Sevilla, Spain) PY20/01282, Generalitat de Catalunya, General Electric 17SGR437, Gilead Sciences GLD17/00282, "Xarxa de Bancs de tumors" - Pla Director d'Oncologia de Catalunya (XBTC), Fondazione AIRC per la ricerca sul cancro Fondazione Cariplo TRIDEO 16923 AIRC IG21436, Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE, Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers forMultipleMyeloma: AMeta-Analysis of Three Large Cohorts and Functional Characterization

  • Clavero, Esther
  • Sánchez Maldonado, José Manuel
  • Jurado Chacón, Manuel
  • Sáinz Pérez, Juan|||0000-0002-9355-2423
European Union’s Horizon 2020 research and innovation program, N 856620, Instituto de Salud Carlos III and FEDER (Madrid, Spain, PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309], National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB), Science and Technology (FCT)—project UIDB/50026/2020, UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts

  • Sáinz Pérez, Juan|||0000-0002-9355-2423
  • Sánchez Maldonado, José Manuel
  • Jurado Chacón, Manuel
Simple Summary We investigated the influence of autophagy-related variants in modulating colorectal cancer (CRC) risk through a meta-analysis of genome-wide association study (GWAS) data from four large European cohorts. We found that genetic variants within the DAPK2 and ATG5 loci were associated with CRC risk. This study also shed some light onto the functional mechanisms behind the observed associations and demonstrated the impact of DAPK2rs11631973 and ATG5rs546456 polymorphisms on the modulation of host immune responses, blood derived-cell counts and serum inflammatory protein levels, which might be involved in promoting cancer development. No effect of the DAPK2 and ATG5 polymorphisms on the autophagy flux was observed, Acknowledgments: We kindly thank all individuals who agreed to participate in the DACHS, CRCGen, CORSA and Czech Republic Colorectal Cancer studies, as well as all cooperating physicians and students. We thank Hugo Sousa for the collection of healthy donors for the autophagy in vitro studies, Data Availability Statement: The genotype data used in the present study are available from the corresponding authors upon reasonable request. Functional data used in this project have been meticulously catalogued and archived in the BBMRI-NL data infrastructure (https://hfgp.bbmri.nl/, accessed on 13 December 2019) using the MOLGENIS open-source platform for scientific data [52]. This allows flexible data querying and download, including sufficiently rich metadata and interfaces for machine processing (R statistics, REST API) and using FAIR principles to optimise findability, accessibility, interoperability and reusability [53,54]., Funding: This work was partially supported by grants from the Instituto de Salud Carlos III (Madrid, Spain; PI12/02688 and PI17/02256). CORSA was funded by the Austrian Research Promotion Agency (FFG) BRIDGE grant (no. 829675, to Andrea Gsur), the “Herzfelder’sche Familienstiftung” (grant to Andrea Gsur). Czech Republic CCS was funded by GACR grants (18–09709S, 19–10543S and 20–03997S), ProgresQ28/1.LF and UNCE/MED/006 grants. This article is based upon work from COST Action CA17118, supported by COST (European Cooperation in Science and Technology). A.K. is a recipient of a Ramalingaswami Re-Retry Faculty Fellowship (Grant; BT/RLF/Re-entry/38/2017) from the Department of Biotechnology (DBT), Government of India (GOI). V.M. received funding from the Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723, the Instituto de Salud Carlos III, co-funded by FEDER funds–a way to build Europe–grants PI14-00613, PI17-00092 and the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE. K.H. was supported by European Union Horizon 2020 grant No. 856620. We thank the CERCA Programme, Generalitat de Catalunya for institutional support., The role of genetic variation in autophagy-related genes in modulating autophagy and cancer is poorly understood. Here, we comprehensively investigated the association of autophagy-related variants with colorectal cancer (CRC) risk and provide new insights about the molecular mechanisms underlying the associations. After meta-analysis of the genome-wide association study (GWAS) data from four independent European cohorts (8006 CRC cases and 7070 controls), two loci, DAPK2 (p = 2.19 × 10−5) and ATG5 (p = 6.28 × 10−4) were associated with the risk of CRC. Mechanistically, the DAPK2rs11631973G allele was associated with IL1 β levels after the stimulation of peripheral blood mononuclear cells (PBMCs) with Staphylococcus aureus (p = 0.002), CD24 + CD38 + CD27 + IgM + B cell levels in blood (p = 0.0038) and serum levels of en-RAGE (p = 0.0068). ATG5rs546456T allele was associated with TNF α and IL1 β levels after the stimulation of PBMCs with LPS (p = 0.0088 and p = 0.0076, respectively), CD14+CD16− cell levels in blood (p = 0.0068) and serum levels of CCL19 and cortisol (p = 0.0052 and p = 0.0074, respectively). Interestingly, no association with autophagy flux was observed. These results suggested an effect of the DAPK2 and ATG5 loci in the pathogenesis of CRC, likely through the modulation of host immune responses., Instituto de Salud Carlos III (Madrid, Spain; PI12/02688 and PI17/02256), CORSA was funded by the Austrian Research Promotion Agency (FFG), BRIDGE grant (no. 829675, to Andrea Gsur), Czech Republic CCS was funded by GACR grants (18–09709S, 19–10543S and 20–03997S), ProgresQ28/1.LF and UNCE/MED/006 grants, COST Action CA17118, supported by COST (European Cooperation in Science and Technology), A.K. is a recipient of a Ramalingaswami Re-Retry Faculty Fellowship (Grant; BT/RLF/Re-entry/38/2017) from the Department of Biotechnology (DBT), Government of India (GOI), Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723, the Instituto de Salud Carlos III, co-funded by FEDER funds–a way to build Europe–grants PI14-00613, PI17-00092 and the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE., European Union Horizon 2020 grant No. 856620, CERCA Programme, Generalitat de Catalunya for institutional support
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

  • Klein, Alison P.
  • Wolpin, Brian M.
  • Risch, Harvey A.
  • Stolzenberg-Solomon, Rachael Z.
  • Mocci, Evelina
  • Zhang, Mingfeng
  • Canzian, Federico
  • Childs, Erica J.
  • Hoskins, Jason W.
  • Jermusyk, Ashley
  • Chen, Fei
  • Neoptolemos, John P.
  • Shu, Xiao-Ou
  • Oberg, Ann L.
  • Severi, Gianluca
  • Olson, Sara H.
  • Pasquali, Claudio
  • Patel, Alpa V.
  • Soucek, Pavel
  • Talar-Wojnarowska, Renata
  • Pezzilli, Raffaele
  • Eeden, Stephen K. van den
  • Porta, Miquel, 1957-
  • Rothman, Nathaniel
  • Scelo, Ghislaine
  • Vodicka, Pavel
  • Sesso, Howard D.
  • Sund, Malin
  • Silverman, Debra T.
  • Wentzensen, Nicolas
  • Smith, Jill P.
  • Tavano, Francesca
  • Zeleniuch-Jacquotte, Anne
  • Thornquist, Mark D.
  • Arslan, Alan A.
  • Tobias, Geoffrey S.
  • Vashist, Yogesh
  • Chanock, Stephen J.
  • Visvanathan, Kala
  • Wactawski-Wende, Jean
  • Wang, Zhaoming
  • Amundadottir, Laufey
  • White, Emily
  • Yu, Herbert
  • Berndt, Sonja I.
  • Yu, Kai
  • Zheng, Wei
  • Kraft, Peter
  • Borgida, Ayelet
  • Li, Donghui
  • Obazee, Ofure
  • Andreotti, Gabriella
  • Brennan, Paul
  • Petersen, Gloria M.
  • Babic, Ana
  • Duell, Eric J.
  • Bamlet, William R.
  • Campa, Daniele
  • Beane Freeman, Laura
  • Blackford, Amanda
  • Chung, Charles C.
  • Borges, Michael
  • Bracci, Paige M.
  • Albanes, Demetrius
  • Brais, Lauren
  • Brenner, Hermann
  • Bueno de Mesquita, H. Bas
  • Funel, Niccola
  • Buring, Julie E.
  • Capurso, Gabriele
  • Cavestro, Giulia Martina
  • Gazouli, Maria
  • Chaffee, Kari G.
  • Dijk, Frederike
  • Cleary, Sean
  • Goggins, Michael
  • Cotterchio, Michelle
  • Zhong, Jun
  • Hartge, Patricia
  • Foretova, Lenka
  • Haiman, Christopher A.
  • Fuchs, Charles S.
  • Gallinger, Steven
  • Gaziano, J. Michael M.
  • Herman, Joseph
  • Giles, Graham G.
  • Giovannucci, Edward L.
  • Hoover, Robert N.
  • Goodman, Gary E.
  • Goodman, Phyllis J.
  • Kaaks, Rudolf
  • Hackert, Thilo
  • Hung, Rayjean J.
  • Hasan, Manal
  • Kogevinas, Manolis
  • Hegyi, Peter
  • Helzlsouer, Kathy J.
  • Holcátová, Ivana
  • Kupcinskas, Juozas
  • Holly, Elizabeth A.
  • Jacobs, Eric J.
  • Lee, I. Min
  • Jamroziak, Krzysztof
  • Lawlor, Rita T.
  • Janout, Vladimir
  • Khaw, Kay-Tee
  • Klein, Eric A.
  • Mohelníková Duchoňová, Beatrice
  • Kooperberg, Charles
  • Milne, Roger L.
  • Kulke, Matthew H.
  • Kurtz, Robert J.
  • Laheru, Daniel
  • Orlow, Irene
  • Landi, Stefano
  • Mambrini, Andrea
  • LeMarchand, Loic
  • Peters, Ulrike
  • Lu, Lingeng
  • Malats, Núria
  • Mannisto, Satu
  • Real, Francisco X.
  • Neale, Rachel E.
In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Here, we find significant evidence of a novel association at rs78417682 (7p12/TNS3, P = 4.35 × 10−8). Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10−14), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10−10), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10−8), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10−8). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA. Expression quantitative trait locus analysis in three independent pancreatic data sets provides molecular support of NOC2L as a pancreatic cancer susceptibility gene.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts

  • Sainz, Juan
  • García Verdejo, Francisco José
  • Martínez Bueno, Manuel
  • Kumar, Abhishek
  • Sánchez Maldonado, José Manuel
  • Díez Villanueva, Anna
  • Vodičková, Ludmila
  • Vymetálková, Veronika
  • Martín Sánchez, Vicente
  • Silva Filho, Miguel Inacio Da
  • Sampaio Marques, Belém
  • Brezina, Stefanie
  • Butterbach, Katja
  • Ter Horst, Rob
  • Hoffmeister, Michael
  • Ludovico, Paula
  • Jurado, Manuel
  • Li, Yang
  • Sánchez Rovira, Pedro
  • Netea, Mihai G.
  • Gsur, Andrea
  • Vodička, Pavel
  • Moreno Aguado, Víctor
  • Hemminki, Kari
  • Brenner, Hermann
  • Chang-Claude, Jenny
  • Försti, Asta
The role of genetic variation in autophagy-related genes in modulating autophagy and cancer is poorly understood. Here, we comprehensively investigated the association of autophagy-related variants with colorectal cancer (CRC) risk and provide new insights about the molecular mechanisms underlying the associations. After meta-analysis of the genome-wide association study (GWAS) data from four independent European cohorts (8006 CRC cases and 7070 controls), two loci, DAPK2 (p = 2.19 × 10-5) and ATG5 (p = 6.28 × 10-4) were associated with the risk of CRC. Mechanistically, the DAPK2rs11631973G allele was associated with IL1 β levels after the stimulation of peripheral blood mononuclear cells (PBMCs) with Staphylococcus aureus (p = 0.002), CD24 + CD38 + CD27 + IgM + B cell levels in blood (p = 0.0038) and serum levels of en-RAGE (p = 0.0068). ATG5rs546456T allele was associated with TNF α and IL1 β levels after the stimulation of PBMCs with LPS (p = 0.0088 and p = 0.0076, respectively), CD14+CD16- cell levels in blood (p = 0.0068) and serum levels of CCL19 and cortisol (p = 0.0052 and p = 0.0074, respectively). Interestingly, no association with autophagy flux was observed. These results suggested an effect of the DAPK2 and ATG5 loci in the pathogenesis of CRC, likely through the modulation of host immune responses.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Germline variants of CYBA and TRPM4 predispose to familial colorectal cancer

  • Zhu, Lizhen
  • Miao, Beiping
  • Dymerska, Dagmara
  • Kuswik, Magdalena
  • Bueno-Martínez, Elena
  • Sanoguera-Miralles, Lara
  • Velasco, Eladio
  • Paramasivam, Nagarajan
  • Schlesner, Matthias
  • Kumar, Abhishek
  • Yuan, Ying
  • Lubinski, Jan
  • Reddy Bandapalli, Obul
  • Hemminki, Kari
  • Försti, Asta
Familial colorectal cancer (CRC) is only partially explained by known germline predisposing genes. We performed whole-genome sequencing in 15 Polish families of many affected individuals, without mutations in known CRC predisposing genes. We focused on loss-of-function variants and functionally characterized them. We identified a frameshift variant in the CYBA gene (c.246delC) in one family and a splice site variant in the TRPM4 gene (c.25–1 G > T) in another family. While both variants were absent or extremely rare in gene variant databases, we identified four additional Polish familial CRC cases and two healthy elderly individuals with the CYBA variant (odds ratio 2.46, 95% confidence interval 0.48–12.69). Both variants led to a premature stop codon and to a truncated protein. Functional characterization of the variants showed that knockdown of CYBA or TRPM4 depressed generation of reactive oxygen species (ROS) in LS174T and HT-29 cell lines. Knockdown of TRPM4 resulted in decreased MUC2 protein production. CYBA encodes a component in the NADPH oxidase system which generates ROS and controls, e.g., bacterial colonization in the gut. Germline CYBA variants are associated with early onset inflammatory bowel disease, supported with experimental evidence on loss of intestinal mucus barrier function due to ROS deficiency. TRPM4 encodes a calcium-activated ion channel, which, in a human colonic cancer cell line, controls calcium-mediated secretion of MUC2, a major component of intestinal mucus barrier. We suggest that the gene defects in CYBA and TRPM4 mechanistically involve intestinal barrier integrity through ROS and mucus biology, which converges in chronic bowel inflammation., L.Z. was supported by Zhejiang University Lu’s Graduate Education International Exchange Fund. E.A.V.’s lab was supported by grants from the Spanish Ministry of Science, Innovation and Universities, Plan Nacional de I+D+I 2013-2016, ISCIII (PI17/00227) co-funded by FEDER from Regional Development European Funds (European Union), and grant CSI242P18 (actuación cofinanciada P.O. FEDER 2014-2020 de Castilla y León) from the Consejería de Educación, Junta de Castilla y León. L.S.-M. was supported by a predoctoral fellowship from the Spanish Association Against Cancer (AECC), Junta Provincial de Valladolid (2019-2023). K.H. was supported by the EU Horizon 2020 program, grant No. 856620. A.K. is a recipient of the Ramalingaswami Re-Retry Faculty Fellowship (Grant; BT/RLF/Re-entry/38/2017). This article is based upon work from COST Action CA17118, supported by COST (European Cooperation in Science and Technology).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

  • García-Martín, Paloma
  • Moñiz Díez, Ana
  • Sánchez Maldonado, José Manuel
  • Cabrera Serrano, Antonio José
  • Horst, Rob ter
  • Benavente, Yolanda
  • Landi, Stefano
  • Macauda, Angelica
  • Clay-Gilmour, Alyssa
  • Hernandez-Mohedo, Francisca
  • Niazi, Yasmeen
  • González-Sierra, Pedro
  • Espinet, Blanca
  • Rodríguez-Sevilla, Juan José
  • Maffei, Rossana
  • Blanco, Gonzalo
  • Giaccherini, Matteo
  • Puiggros, Anna
  • Cerhan, James
  • Marasca, Roberto
  • Cañadas-Garre, Marisa
  • López-Nevot, Miguel Ángel
  • Chen-Liang, Tzu
  • Thomsen, Hauke
  • Gámez, Irene
  • Moreno, Víctor
  • Marcos-Gragera, Rafael
  • García-Alvarez, María
  • Llorca, Javier
  • Jerez, Andrés
  • Berndt, Sonja
  • Butrym, Aleksandra
  • Norman, Aaron D.
  • Casabonne, Delphine
  • Luppi, Mario
  • Slager, Susan L.
  • Hemminki, Kari
  • Li, Yang
  • Alcoceba, Miguel
  • Campa, Daniele
  • Canzian, Federico
  • Sanjosé, Silvia de
  • Försti, Asta
  • Netea, Mihai
  • Jurado, Manuel
  • Sainz, Juan
During the past years, considerable efforts have been made to uncover the genetic component of chronic lymphocytic leukemia (CLL) susceptibility. To date, several genome-wide association studies (GWAS) and their meta-analysis have identified not only single-nucleotide polymorphisms (SNPs) associated with CLL risk [1] but also patient survival [2]. However, despite these noticeable results, it becomes evident that both validation and functional characterization of the genetic variations identified are still required before they can be used in a clinical setting. Hence, we decided to validate the association of 41 GWAS-identified hits for CLL in 1158 CLL cases and 1947 controls ascertained through the Consortium for Research in Chronic lymphocytIc Leukemia (CRuCIAL) and to investigate their impact on modulating host immune responses and their utility to predict disease onset. Study participants were of European ancestry and gave their written informed consent to participate in the study, which was approved by the ethical review committee of participant institutions. CLL patients had often Binet stage A and Rai stage I (67.00% and 79.83%) and, compared to controls, had a higher mean age (66.19 ± 12.66 vs. 55.60 ± 11.50) and an increased male/female ratio (1.54 vs. 0.91). SNPs selection was based on published GWAS, functionality according to HaploReg data, and linkage disequilibrium between the SNPs. Genotyping of genetic variants was performed using KASPTM and Taqman® assays. Hardy–Weinberg equilibrium was assessed in the controls (P > 0.001) and the association between CLL and SNPs was tested using a multivariate unconditional logistic regression analysis adjusted for age, sex, and country of origin. A meta-analysis of the CRuCIAL results with those from previous GWAS was conducted to validate genetic associations and the I [2] statistic was used to assess statistical heterogeneity between the studies (PHet > 0.01). The pooled OR was computed using the fixed-effect model and the significance threshold for the meta-analysis was set to 5.0 × 10−8. Mechanistically, we evaluated the correlation of the GWAS-identified SNPs with a production of nine cytokines after in vitro stimulation of whole blood, peripheral mononuclear cells, and monocyte-derived macrophages from 408 healthy subjects of the Human Functional Genomic Project (HFGP) with LPS, PHA, Pam3Cys, CpG and Borrelia burgdorferi and Escherichia coli. In parallel, we also tested the correlation between selected SNPs and circulating concentrations of 103 serum and plasmatic inflammatory proteins, 7 plasma steroid hormones, and absolute numbers of 91 blood-derived immune cell populations. The HFGP study was approved by the Arnhem-Nijmegen Ethical Committee (42561.091.12) and biological specimens were collected after informed consent was obtained. A detailed description of the study population and participating centers, selected SNPs and protocols and reagents used in the functional experiments are included in the Supplementary Material available on the Blood Cancer Journal website. In order to account for multiple comparisons, we used a significance threshold of 2.3 × 10−5, 1.2 × 10−5, 1.34 × 10−5, and 1.74 × 10−4 for the cytokine quantitative trait loci, proteomic, blood cell counts, and steroid hormone analyses, respectively., This work was partially supported by the European Union’s Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejería de Economía, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-UGR18); Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Sevilla, Spain; PY20/01282); Generalitat de Catalunya (17SGR437); Gilead Sciences Fellowship (GLD17/00282); the “Xarxa de Bancs de tumors“ sponsored by Pla Director d’Oncologia de Catalunya (XBTC); the Associazione Italiana per la Ricerca sul Cancro and Fondazione Cariplo (TRIDEO 16923 and AIRC IG21436); the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; and the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

  • Cabrera Serrano, Antonio José
  • Sánchez Maldonado, José Manuel
  • Ter Horst, Rob
  • Macauda, Angelica
  • García-Martín, Paloma
  • Benavente, Yolanda
  • Landi, Stefano
  • Clay-Gilmour, Alyssa
  • Niazi, Yasmeen
  • Espinet, Blanca
  • Rodríguez-Sevilla, Juan José
  • Pérez, Eva María
  • Maffei, Rossana
  • Blanco, Gonzalo
  • Giaccherini, Matteo
  • Cerhan, James R
  • Marasca, Roberto
  • López-Nevot, Miguel Ángel
  • Chen-Liang, Tzu
  • Thomsen, Hauke
  • Gámez, Irene
  • Campa, Daniele
  • Moreno, Víctor
  • Sanjosé, Silvia de
  • Marcos-Gragera, Rafael
  • García-Alvarez, María
  • Dierssen-Sotos, Trinidad
  • Jerez, Andrés
  • Butrym, Aleksandra
  • Norman, Aaron D.
  • Luppi, Mario
  • Slager, Susan L.
  • Hemminki, Kari
  • Li, Yang
  • Berndt, Sonja I.
  • Casabonne, Delphine
  • Alcoceba, Miguel
  • Puiggros, Anna
  • Netea, Mihai G.
  • Försti, Asta
  • Canzian, Federico
  • Sainz, Juan
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845) and from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades y FEDER (PY20/01282). “The Mayo studies in InterLymph were supported in part by the US National Cancer Institute grants P50 CA97274 and R01 CA92153.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of novel genetic loci for risk of multiple myeloma by functional annotation

  • Macauda, Angelica
  • Briem, Klara
  • Clay-Gilmour, Alyssa
  • Cozen, Wendy
  • Försti, Asta
  • Giaccherini, Matteo
  • Corradi, Chiara
  • Sainz, Juan
  • Niazi, Yasmeen
  • Ter Horst, Rob
  • Li, Yang
  • Netea, Mihai G.
  • Vogel, Ulla
  • Hemminki, Kari
  • Slager, Susan L.
  • Varkonyi, Judit
  • Andersen, Vibeke
  • Iskierka-Jazdzewska, Elżbieta
  • Martínez-López, Joaquín
  • Zaucha, Jan
  • Camp, Nicola J.
  • Rajkumar, S. Vincent
  • Druzd-Sitek, Agnieszka
  • Bhatti, Parveen
  • Chanock, Stephen J.
  • Kumar, Shaji K.
  • Subocz, Edyta
  • Mazur, Grzegorz
  • Landi, Stefano
  • Machiela, Mitchell J.
  • Jerez, Andrés
  • Norman, Aaron D.
  • Hildebrandt, Michelle A. T.
  • Kadar, Katalin
  • Berndt, Sonja I.
  • Ziv, Elad
  • Buda, Gabriele
  • Nagler, Arnon
  • Dumontet, Charles
  • Raźny, Malgorzata
  • Watek, Marzena
  • Butrym, Aleksandra
  • Grzasko, Norbert
  • Dudzinski, Marek
  • Rybicka-Ramos, Malwina
  • Matera, Eva-Laure
  • García-Sanz, Ramón
  • Goldschmidt, Hartmut
  • Jamroziak, Krzysztof
  • Jurczyszyn, Artur
  • Clavero, Esther
  • Giles, Graham G.
  • Pelosini, Matteo
  • Zawirska, Daria
  • Kruszewski, Marcin
  • Marques, Herlander
  • Haastrup, Eva
  • Sánchez Maldonado, José Manuel
  • Bertsch, Uta
  • Rymko, Marcin
  • Raab, Marc-Steffen
  • Brown, Elizabeth E.
  • Hofmann, Jonathan N.
  • Vachon, Celine
  • Campa, Daniele
  • Canzian, Federico
Multiple myeloma (MM) is one of the most common hematological malignancies, accounting for 20% of all newly diagnosed hematological cancers [1]. The most recent data from Cancer Today show that in 2020 the number of new MM cases was 176,404 worldwide, This work was partially supported by: intramural funding of DKFZ; Horizon 2020 of the European Union, grant 856620; the Intramural Research Program of the National Cancer Institute, National Institutes of Health, grant number U01CA271014 and U01 CA249955. Open Access funding enabled and organized by Projekt DEAL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

  • Clavero, Esther
  • Sanchez-Maldonado, José Manuel
  • Macauda, Angélica
  • Ter Horst, Rob
  • Sampaio-Marques, Belém
  • Jurczyszyn, Artur
  • Clay-Gilmour, Alyssa
  • Stein, Angelika
  • Hildebrandt, Michelle A. T.
  • Weinhold, Niels
  • Buda, Gabriele
  • García-Sanz, Ramón
  • Tomczak, Waldemar
  • Vogel, Ulla
  • Jerez, Andrés
  • Zawirska, Daria
  • Wątek, Marzena
  • Hofmann, Jonathan N.
  • Landi, Stefano
  • Spinelli, John J.
  • Butrym, Aleksandra
  • Kumar, Abhishek
  • Martínez-López, Joaquín
  • Galimberti, Sara
  • Sarasquete, María Eugenia
  • Subocz, Edyta
  • Iskierka-Jazdzewska, Elżbieta
  • Giles, Graham G.
  • Rybicka-Ramos, Malwina
  • Kruszewski, Marcin
  • Abildgaard, Niels
  • Verdejo, Francisco García
  • Sánchez Rovira, Pedro
  • da Silva Filho, Miguel Inacio
  • Kadar, Katalin
  • Razny, Małgorzata
  • Cozen, Wendy
  • Pelosini, Matteo
  • Jurado, Manuel
  • Bhatti, Parveen
  • Dudzinski, Marek
  • Druzd-Sitek, Agnieszka
  • Orciuolo, Enrico
  • Li, Yang
  • Norman, Aaron D.
  • Zaucha, Jan Maciej
  • Reis, Rui Manuel
  • Markiewicz, Miroslaw
  • Rodríguez Sevilla, Juan José
  • Andersen, Vibeke
  • Jamroziak, Krzysztof
  • Hemminki, Kari
  • Berndt, Sonja I.
  • Rajkumar, Vicent
  • Mazur, Grzegorz
  • Kumar, Shaji K.
  • Ludovico, Paula
  • Nagler, Arnon
  • Chanock, Stephen J.
  • Dumontet, Charles
  • Machiela, Mitchell J.
  • Varkonyi, Judit
  • Camp, Nicola J.
  • Ziv, Elad
  • Vangsted, Annette Juul
  • Brown, Elizabeth E.
  • Campa, Daniele
  • Vachon, Celine M.
  • Netea, Mihai G.
  • Canzian, Federico
  • Försti, Asta
  • Sainz, Juan
Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10−9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10−4−5.79 × 10−14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10−4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10−4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10−4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3− B cells, CD5+IgD− cells, IgM− cells, IgD−IgM− cells, and CD4−CD8− PBMCs (p = 4.9 × 10−4−8.6 × 10−4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27− cells (p = 9.3 × 10−4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3−, MCP-2−, and IL20-dependent pathways., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB). This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

  • García-Martín, Paloma
  • Espinet Solà, Blanca
  • Rodríguez-Sevilla, Juan José
  • Blanco Ares, Gonzalo, 1989-
  • Puiggros Metje, Anna Maria
  • Sainz, Juan
This work was partially supported by the European Union’s Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejería de Economía, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-UGR18); Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Sevilla, Spain; PY20/01282); Generalitat de Catalunya (17SGR437); Gilead Sciences Fellowship (GLD17/00282); the “Xarxa de Bancs de tumors“ sponsored by Pla Director d’Oncologia de Catalunya (XBTC); the Associazione Italiana per la Ricerca sul Cancro and Fondazione Cariplo (TRIDEO 16923 and AIRC IG21436); the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; and the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

  • Clavero, Esther
  • ter Horst, Rob
  • Sampaio-Marques, Belém
  • Jurczyszyn, Artur
  • Sánchez Maldonado, Jose Manuel
  • Macauda, Angelica
  • Jerez, Andres
Autophagy; Genetic variants; Multiple myeloma, Autofagia; Variantes genéticas; Mieloma múltiple, Autofàgia; Variants genètiques; Mieloma múltiple, Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10−9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10−4−5.79 × 10−14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10−4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10−4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10−4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3− B cells, CD5+IgD− cells, IgM− cells, IgD−IgM− cells, and CD4−CD8− PBMCs (p = 4.9 × 10−4−8.6 × 10−4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27− cells (p = 9.3 × 10−4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3−, MCP-2−, and IL20-dependent pathways., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB). This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts

  • Sainz, Juan
  • García Verdejo, Francisco José
  • Martínez Bueno, Manuel
  • Kumar, Abhishek
  • Sánchez Maldonado, José Manuel
  • Díez Villanueva, Anna
  • Vodičková, Ludmila
  • Vymetálková, Veronika
  • Martín Sánchez, Vicente
  • Silva Filho, Miguel Inacio Da
  • Sampaio Marques, Belém
  • Brezina, Stefanie
  • Butterbach, Katja
  • Ter Horst, Rob
  • Hoffmeister, Michael
  • Ludovico, Paula
  • Jurado, Manuel
  • Li, Yang
  • Sánchez Rovira, Pedro
  • Netea, Mihai G.
  • Gsur, Andrea
  • Vodička, Pavel
  • Moreno Aguado, Víctor
  • Hemminki, Kari
  • Brenner, Hermann
  • Chang-Claude, Jenny
  • Försti, Asta
The role of genetic variation in autophagy-related genes in modulating autophagy and cancer is poorly understood. Here, we comprehensively investigated the association of autophagy-related variants with colorectal cancer (CRC) risk and provide new insights about the molecular mechanisms underlying the associations. After meta-analysis of the genome-wide association study (GWAS) data from four independent European cohorts (8006 CRC cases and 7070 controls), two loci, DAPK2 (p = 2.19 × 10-5) and ATG5 (p = 6.28 × 10-4) were associated with the risk of CRC. Mechanistically, the DAPK2rs11631973G allele was associated with IL1 β levels after the stimulation of peripheral blood mononuclear cells (PBMCs) with Staphylococcus aureus (p = 0.002), CD24 + CD38 + CD27 + IgM + B cell levels in blood (p = 0.0038) and serum levels of en-RAGE (p = 0.0068). ATG5rs546456T allele was associated with TNF α and IL1 β levels after the stimulation of PBMCs with LPS (p = 0.0088 and p = 0.0076, respectively), CD14+CD16- cell levels in blood (p = 0.0068) and serum levels of CCL19 and cortisol (p = 0.0052 and p = 0.0074, respectively). Interestingly, no association with autophagy flux was observed. These results suggested an effect of the DAPK2 and ATG5 loci in the pathogenesis of CRC, likely through the modulation of host immune responses.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Do gwas-identified risk variants for chronic lymphocytic leukemia influence overall patient survival and disease progression?

  • Cabrera Serrano, Antonio José
  • Espinet Solà, Blanca
  • Blanco Ares, Gonzalo, 1989-
  • Puiggros Metje, Anna Maria
  • Sainz, Juan
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845) and from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades y FEDER (PY20/01282). “The Mayo studies in InterLymph were supported in part by the US National Cancer Institute grants P50 CA97274 and R01 CA92153.”
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

  • Klein, Alison P.
  • Wolpin, Brian M.
  • Risch, Harvey A.
  • Stolzenberg-Solomon, Rachael Z.
  • Mocci, Evelina
  • Zhang, Mingfeng
  • Canzian, Federico
  • Childs, Erica J.
  • Hoskins, Jason W.
  • Jermusyk, Ashley
  • Chen, Fei
  • Neoptolemos, John P.
  • Shu, Xiao-Ou
  • Oberg, Ann L.
  • Severi, Gianluca
  • Olson, Sara H.
  • Pasquali, Claudio
  • Patel, Alpa V.
  • Soucek, Pavel
  • Talar-Wojnarowska, Renata
  • Pezzilli, Raffaele
  • Eeden, Stephen K. van den
  • Porta, Miquel, 1957-
  • Rothman, Nathaniel
  • Scelo, Ghislaine
  • Vodicka, Pavel
  • Sesso, Howard D.
  • Sund, Malin
  • Silverman, Debra T.
  • Wentzensen, Nicolas
  • Smith, Jill P.
  • Tavano, Francesca
  • Zeleniuch-Jacquotte, Anne
  • Thornquist, Mark D.
  • Arslan, Alan A.
  • Tobias, Geoffrey S.
  • Vashist, Yogesh
  • Chanock, Stephen J.
  • Visvanathan, Kala
  • Wactawski-Wende, Jean
  • Wang, Zhaoming
  • Amundadottir, Laufey
  • White, Emily
  • Yu, Herbert
  • Berndt, Sonja I.
  • Yu, Kai
  • Zheng, Wei
  • Kraft, Peter
  • Borgida, Ayelet
  • Li, Donghui
  • Obazee, Ofure
  • Andreotti, Gabriella
  • Brennan, Paul
  • Petersen, Gloria M.
  • Babic, Ana
  • Duell, Eric J.
  • Bamlet, William R.
  • Campa, Daniele
  • Beane Freeman, Laura
  • Blackford, Amanda
  • Chung, Charles C.
  • Borges, Michael
  • Bracci, Paige M.
  • Albanes, Demetrius
  • Brais, Lauren
  • Brenner, Hermann
  • Bueno de Mesquita, H. Bas
  • Funel, Niccola
  • Buring, Julie E.
  • Capurso, Gabriele
  • Cavestro, Giulia Martina
  • Gazouli, Maria
  • Chaffee, Kari G.
  • Dijk, Frederike
  • Cleary, Sean
  • Goggins, Michael
  • Cotterchio, Michelle
  • Zhong, Jun
  • Hartge, Patricia
  • Foretova, Lenka
  • Haiman, Christopher A.
  • Fuchs, Charles S.
  • Gallinger, Steven
  • Gaziano, J. Michael M.
  • Herman, Joseph
  • Giles, Graham G.
  • Giovannucci, Edward L.
  • Hoover, Robert N.
  • Goodman, Gary E.
  • Goodman, Phyllis J.
  • Kaaks, Rudolf
  • Hackert, Thilo
  • Hung, Rayjean J.
  • Hasan, Manal
  • Kogevinas, Manolis
  • Hegyi, Peter
  • Helzlsouer, Kathy J.
  • Holcátová, Ivana
  • Kupcinskas, Juozas
  • Holly, Elizabeth A.
  • Jacobs, Eric J.
  • Lee, I. Min
  • Jamroziak, Krzysztof
  • Lawlor, Rita T.
  • Janout, Vladimir
  • Khaw, Kay-Tee
  • Klein, Eric A.
  • Mohelníková Duchoňová, Beatrice
  • Kooperberg, Charles
  • Milne, Roger L.
  • Kulke, Matthew H.
  • Kurtz, Robert J.
  • Laheru, Daniel
  • Orlow, Irene
  • Landi, Stefano
  • Mambrini, Andrea
  • LeMarchand, Loic
  • Peters, Ulrike
  • Lu, Lingeng
  • Malats, Núria
  • Mannisto, Satu
  • Real, Francisco X.
  • Neale, Rachel E.
In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Here, we find significant evidence of a novel association at rs78417682 (7p12/TNS3, P = 4.35 × 10−8). Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10−14), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10−10), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10−8), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10−8). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA. Expression quantitative trait locus analysis in three independent pancreatic data sets provides molecular support of NOC2L as a pancreatic cancer susceptibility gene.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Polymorphisms within autophagy-related genes as susceptibility biomarkers for multiple myeloma: a meta-analysis of three large cohorts and functional characterization

  • Clavero, Esther
  • Rodríguez-Sevilla, Juan José
  • Sainz, Juan
Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10-9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10-4-5.79 × 10-14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10-4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10-4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10-4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3- B cells, CD5+IgD- cells, IgM- cells, IgD-IgM- cells, and CD4-CD8- PBMCs (p = 4.9 × 10-4-8.6 × 10-4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27- cells (p = 9.3 × 10-4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3-, MCP-2-, and IL20-dependent pathways., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB). This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).
Docta Complutense
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

  • Clavero, Esther
  • Martínez López, Joaquín
  • Sainz, Juan
Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10−9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10−4−5.79 × 10−14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10−4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10−4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10−4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3− B cells, CD5+IgD− cells, IgM− cells, IgD−IgM− cells, and CD4−CD8− PBMCs (p = 4.9 × 10−4−8.6 × 10−4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27− cells (p = 9.3 × 10−4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3−, MCP-2−, and IL20-dependent pathways.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia, a CRuCIAL study

  • García Martín, Paloma|||0000-0001-5582-8575
  • Moñiz Díez, Ana|||0000-0002-3260-9553
  • Sánchez Maldonado, José Manuel|||0000-0002-4651-3675
  • Cabrera Serrano, Antonio José|||0000-0003-0346-7960
  • ter Horst, Rob|||0000-0003-0576-5873
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Landi, Stefano|||0000-0001-8364-6357
  • Macauda, Angelica|||0000-0001-9820-5079
  • Clay-Gilmour, Alyssa|||0000-0001-9998-4879
  • Hernández-Mohedo, Francisca
  • Niazi, Yasmeen|||0000-0002-7560-2247
  • González-Sierra, Pedro Antonio|||0000-0002-6492-1728
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rodriguez-Sevilla, Juan Jose|||0000-0002-4741-7925
  • Maffei, Rossana|||0000-0002-3518-2006
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Giaccherini, Matteo|||0000-0002-0363-6632
  • Puiggros, Anna|||0000-0001-9627-4978
  • Cerhan, James|||0000-0002-7482-178X
  • Marasca, Roberto|||0000-0002-6431-6878
  • Cañadas-Garre, Marisa|||0000-0003-1103-5658
  • Lopez Nevot, Miguel Angel|||0000-0002-3465-6062
  • Chen-Liang, Tzu|||0000-0001-5969-8640
  • Thomsen, Hauke|||0000-0001-5951-3116
  • Gámez, Irene
  • Morros, Rosa|||0000-0001-6752-8748
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • García-Álvarez, María|||0000-0001-8864-1168
  • Llorca, Javier|||0000-0001-8569-861X
  • Jerez, Andrés|||0000-0002-2079-6638
  • Berndt, Sonja
  • Butrym, Aleksandra|||0000-0002-8199-2018
  • Norman, Aaron D.|||0000-0002-4208-2708
  • Casabonne, Delphine
  • Luppi, Mario|||0000-0002-0373-1154
  • Slager, Susan|||0000-0002-5173-4712
  • Hemminki, Kari|||0000-0002-2769-3316
  • Li, Yang
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Campa, Daniele|||0000-0003-3220-9944
  • Canzian, Federico|||0000-0002-4261-4583
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Försti, Asta|||0000-0002-9857-4728
  • Netea, Mihai G.|||0000-0003-2421-6052
  • Jurado, Manuel|||0000-0001-9156-3797
  • Sainz, Juan|||0000-0002-9355-2423
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

  • Cabrera Serrano, Antonio José|||0000-0003-0346-7960
  • Sánchez Maldonado, José Manuel|||0000-0002-4651-3675
  • ter Horst, Rob|||0000-0003-0576-5873
  • Macauda, Angelica|||0000-0001-9820-5079
  • García Martín, Paloma|||0000-0001-5582-8575
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Landi, Stefano|||0000-0001-8364-6357
  • Clay-Gilmour, Alyssa|||0000-0001-9998-4879
  • Niazi, Yasmeen|||0000-0002-7560-2247
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rodriguez-Sevilla, Juan Jose|||0000-0002-4741-7925
  • Pérez, Eva María
  • Maffei, Rossana|||0000-0002-3518-2006
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Giaccherini, Matteo|||0000-0002-0363-6632
  • Cerhan, James R.
  • Marasca, Roberto|||0000-0002-6431-6878
  • Lopez Nevot, Miguel Angel|||0000-0002-3465-6062
  • Chen-Liang, Tzu Hua
  • Thomsen, Hauke|||0000-0001-5951-3116
  • Gámez, Irene
  • Campa, Daniele|||0000-0003-3220-9944
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • de Sanjosé, Silvia
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • García-Álvarez, María Flor
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Jerez, Andrés|||0000-0002-2079-6638
  • Butrym, Aleksandra|||0000-0002-8199-2018
  • Norman, Aaron D.|||0000-0002-4208-2708
  • Luppi, Mario|||0000-0002-0373-1154
  • Slager, Susan|||0000-0002-5173-4712
  • Hemminki, Kari|||0000-0002-2769-3316
  • Li, Yang
  • Berndt, Sonja
  • Casabonne, Delphine
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Puiggros, Anna|||0000-0001-9627-4978
  • Netea, Mihai G.|||0000-0003-2421-6052
  • Försti, Asta|||0000-0002-9857-4728
  • Canzian, Federico|||0000-0002-4261-4583
  • Sainz, Juan|||0000-0002-9355-2423
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

  • Clavero, Esther
  • ter Horst, Rob
  • Sampaio-Marques, Belém
  • Jurczyszyn, Artur
  • Sánchez Maldonado, Jose Manuel
  • Macauda, Angelica
  • Jerez, Andres
Autophagy; Genetic variants; Multiple myeloma, Autofagia; Variantes genéticas; Mieloma múltiple, Autofàgia; Variants genètiques; Mieloma múltiple, Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10−9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10−4−5.79 × 10−14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10−4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10−4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10−4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3− B cells, CD5+IgD− cells, IgM− cells, IgD−IgM− cells, and CD4−CD8− PBMCs (p = 4.9 × 10−4−8.6 × 10−4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27− cells (p = 9.3 × 10−4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3−, MCP-2−, and IL20-dependent pathways., This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB). This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).